Rang	Name	Position
1	Dr. Frederick G. Vogt Esq., J.D., Ph.D.	Interim CEO, President, General Counsel, Corporate Secretary & Director
2	Ms. Corleen M. Roche	Chief Financial Officer
3	Dr. Igor P. Bilinsky Ph.D.	Chief Operating Officer
4	Dr. Raj K. Puri M.D., Ph.D.	Chief Regulatory Officer
5	Mr. Daniel G. Kirby	Chief Commercial Officer
6	Ms. Sara Pellegrino	Senior Vice President of Investor Relations & Corporate Communications
7	Ms. Tracy Winton	Executive Vice President of Human Resources
8	Mr. Howard B. Johnson M.B.A.	Chief Business Officer
9	Mr. Kevin Smyth	Executive Vice President of Quality
10	Dr. Brian Gastman M.D.	Executive Vice President of Translational Medicine & Research

Aufteilung der Investoren

Rang	Inhaber	Anteile	Wert
1	BlackRock Inc	6,86%	0,27 Mrd. USD
2	Mhr Fund Management Llc	6,39%	0,25 Mrd. USD
3	Two Sigma Investments LLC	4,20%	0,16 Mrd. USD
4	State Street Corp	3,85%	0,15 Mrd. USD
5	Vanguard Capital Management, LLC	3,67%	0,14 Mrd. USD
6	Vanguard Portfolio Management, LLC	2,58%	0,10 Mrd. USD
7	The Goldman Sachs Group Inc	1,93%	0,08 Mrd. USD
8	Geode Capital Management, LLC	1,89%	0,07 Mrd. USD
9	Millennium Management LLC	1,88%	0,07 Mrd. USD
10	Invenomic Capital Management, LP	1,88%	0,07 Mrd. USD
11	Bank of America Corp	1,87%	0,07 Mrd. USD
12	Dimensional Fund Advisors, Inc.	1,43%	0,06 Mrd. USD
13	Morgan Stanley - Brokerage Accounts	1,37%	0,05 Mrd. USD
14	Palo Alto Investors, LLC	1,17%	0,05 Mrd. USD
15	Jupiter Asset Management Limited	1,00%	0,04 Mrd. USD
16	Jane Street Group LLC	0,92%	0,04 Mrd. USD
17	Nuveen, LLC	0,81%	0,03 Mrd. USD
18	HRT FINANCIAL LLC	0,77%	0,03 Mrd. USD
19	T. Rowe Price Associates, Inc.	0,70%	0,03 Mrd. USD
20	Susquehanna International Group, LLP	0,66%	0,03 Mrd. USD